[1]
|
Jemal, A., Ward, E.M., et al. (2017) Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. JNCI: Journal of the National Cancer Institute, 109, djx030. https://doi.org/10.1093/jnci/djx030
|
[2]
|
Villanueva, A. (2019) Hepatocellular Carcinoma. The New England Journal of Medicine, 380, 1450-1462.
https://doi.org/10.1056/NEJMra1713263
|
[3]
|
Chen, Z., Xie, H., Hu, M., et al. (2020) Recent Progress in Treatment of Hepatocellular Carcinoma. American Journal of Cancer Research, 10, 2993-3036.
|
[4]
|
Bruix, J., Cheng, A.L., Meinhardt, G., et al. (2017) Prognostic Factors and Predictors of Sorafenib Benefit in Patients with Hepatocellular Carcinoma: Analysis of Two-Phase III Studies. Journal of Hepatology, 67, 999-1008.
https://doi.org/10.1016/j.jhep.2017.06.026
|
[5]
|
Kudo, M., Finn, R.S., Qin, S., et al. (2018) Lenvatinib versus Sorafenib in First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Randomized Phase 3 Non-Inferiority Trial. The Lancet, 391, 1163-1173.
https://doi.org/10.1016/S0140-6736(18)30207-1
|
[6]
|
Wang, Y., Zheng, L., Shang, W., et al. (2022) Wnt/β-Catenin Signaling Confers Ferroptosis Resistance by Targeting GPX4 in Gastric Cancer. Cell Death and Differentiation, 29, 2190-2202. https://doi.org/10.1038/s41418-022-01008-w
|
[7]
|
Morales, M. and Xue, X. (2021) Targeting Iron Metabolism in Cancer Therapy. Theranostics, 11, 8412-8429.
https://doi.org/10.7150/thno.59092
|
[8]
|
Li, J., Cao, F., Yin, H.L., et al. (2020) Ferroptosis: Past, Present and Future. Cell Death & Disease, 11, Article No. 88.
https://doi.org/10.1038/s41419-020-2298-2
|
[9]
|
Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. https://doi.org/10.1016/j.cell.2012.03.042
|
[10]
|
Cairns, R.A., Harris, I.S. and Mak, T.W. (2011) Regulation of Cancer Cell Metabolism. Nature Reviews Cancer, 11, 85-95. https://doi.org/10.1038/nrc2981
|
[11]
|
Diehn, M., Cho, R.W., Lobo, N.A., et al. (2009) Association of Reactive Oxygen Species Levels and Radio-Resistance in Cancer Stem Cells. Nature, 458, 780-783. https://doi.org/10.1038/nature07733
|
[12]
|
Kenny, E.F., Herzig, A., Krüger, R., et al. (2017) Diverse Stimuli Engage Different Neutrophil Extracellular Trap Pathways. eLife, 6, e24437. https://doi.org/10.7554/eLife.24437
|
[13]
|
Jones, R.M. and Neish, A.S. (2017) Redox Signaling Mediated by the Gut Microbiota. Free Radical Biology & Medicine, 105, 41-47. https://doi.org/10.1016/j.freeradbiomed.2016.10.495
|
[14]
|
Nathan, C. and Cunningham-Bussel, A. (2013) Beyond Oxidative Stress: An Immunologist’s Guide to Reactive Oxygen Species. Nature Reviews Immunology, 13, 349-361. https://doi.org/10.1038/nri3423
|
[15]
|
Salehi, F., Behboudi, H., Kavoosi, G. and Ardestani, S.K. (2018) Oxidative DNA Damage Induced by ROS-Modulating Agents with the Ability to Target DNA: A Comparison of the Biological Characteristics of Citrus Pectin and Apple Pectin. Scientific Reports, 8, Article No. 13902. https://doi.org/10.1038/s41598-018-32308-2
|
[16]
|
Shokolenko, I., Venediktova, N., Bochkareva, A., Wilson, G.L. and Alexeyev, M.F. (2009) Oxidative Stress Induces Degradation of Mitochondrial DNA. Nucleic Acids Research, 37, 2539-2548. https://doi.org/10.1093/nar/gkp100
|
[17]
|
Chocry, M. and Leloup, L. (2020) The NADPH Oxidase Family and Its Inhibitors. Antioxidants & Redox Signaling, 33, 332-353. https://doi.org/10.1089/ars.2019.7915
|
[18]
|
Li, R., Jia, Z. and Trush, M.A. (2016) Defining ROS in Biology and Medicine. Reactive Oxygen Species, 1, 9-21.
https://doi.org/10.20455/ros.2016.803
|
[19]
|
Zorov, D.B., Juhaszova, M. and Sollott, S.J. (2014) Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release. Physiological Reviews, 94, 909-950. https://doi.org/10.1152/physrev.00026.2013
|
[20]
|
Kang, S.W., Lee, S. and Lee, E.K. (2015) ROS and Energy Metabolism in Cancer Cells: Alliance for Fast Growth. Archives of Pharmacal Research, 38, 338-345. https://doi.org/10.1007/s12272-015-0550-6
|
[21]
|
Valko, M., Leibfritz, D., Moncol, J., et al. (2007) Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease. International Journal of Biochemistry & Cell Biology, 39, 44-84.
https://doi.org/10.1016/j.biocel.2006.07.001
|
[22]
|
He, L., He, T., Farrar, S., et al. (2017) Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cellular Physiology and Biochemistry, 44, 532-553. https://doi.org/10.1159/000485089
|
[23]
|
Scortegagna, M., Ding, K., Oktay, Y., et al. (2003) Multiple Organ Pathology, Metabolic Abnormalities and Impaired Homeostasis of Reactive Oxygen Species in Epas1−/− Mice. Nature Genetics, 35, 331-340.
https://doi.org/10.1038/ng1266
|
[24]
|
Leavy, O. (2014) Inflammation: Regulating ROS. Nature Reviews Immunology, 14, Article No. 357.
https://doi.org/10.1038/nri3685
|
[25]
|
Park, E. and Chung, S.W. (2019) ROS-Mediated Autophagy Increases Intracellular Iron Levels and Ferroptosis by Ferritin and Transferrin Receptor Regulation. Cell Death & Disease, 10, Article No. 822.
https://doi.org/10.1038/s41419-019-2064-5
|
[26]
|
Moloney, J.N. and Cotter, T.G. (2018) ROS Signaling in the Biology of Cancer. Seminars in Cell & Developmental Biology, 80, 50-64. https://doi.org/10.1016/j.semcdb.2017.05.023
|
[27]
|
Fan, X.X., Pan, H.D., Li, Y., et al. (2018) Novel Therapeutic Strategy for Cancer and Autoimmune Conditions: Modulating Cell Metabolism and Redox Capacity. Pharmacology & Therapeutics, 191, 148-161.
https://doi.org/10.1016/j.pharmthera.2018.06.010
|
[28]
|
武一凡, 卢娜. 基于细胞氧化还原平衡的抗肿瘤新靶点及其药物的研究进展[J]. 世界最新医学信息文摘, 2019(30): 3.
|
[29]
|
Wang, K., Jiang, J., Lei, Y., et al. (2019) Targeting Metabolic-Redox Circuits for Cancer Therapy. Trends in Biochemical Sciences, 44, 401-414. https://doi.org/10.1016/j.tibs.2019.01.001
|
[30]
|
Trachootham, D., Alexandre, J. and Huang, P. (2009) Targeting Cancer Cells by ROS-Mediated Mechanisms: A Radical Therapeutic Approach? Nature Reviews Drug Discovery, 8, 579-591. https://doi.org/10.1038/nrd2803
|
[31]
|
Marinho, H.S., Real, C., Cyrne, L., Soares, H. and Antunes, F. (2014) Hydrogen Peroxide Sensing, Signaling and Regulation of Transcription Factors. Redox Biology, 2, 535-562. https://doi.org/10.1016/j.redox.2014.02.006
|
[32]
|
Jones, D.P. (2008) Radical-Free Biology of Oxidative Stress. American Journal of Physiology-Cell Physiology, 295, C849-C868. https://doi.org/10.1152/ajpcell.00283.2008
|
[33]
|
Zhang, W., Xiao, S. and Ahn, D.U. (2013) Protein Oxidation: Basic Principles and Implications for Meat Quality. Critical Reviews in Food Science and Nutrition, 53, 1191-1201. https://doi.org/10.1080/10408398.2011.577540
|
[34]
|
Mohsin, A., Haneef, K., Ilyas, A., Zarina, S. and Hashim, Z. (2021) Oxidative Stress Induced Cell Cycle Arrest: Potential Role of PRX-2 and GSTP-1 as Therapeutic Targets in Hepatocellular Carcinoma. Protein and Peptide Letters, 28, 1323-1329. https://doi.org/10.2174/0929866528666211105105953
|
[35]
|
Maki, A., Kono, H., Gupta, M., et al. (2007) Predictive Power of Biomarkers of Oxidative Stress and Inflammation in Patients with Hepatitis C Virus-Associated Hepatocellular Carcinoma. Annals of Surgical Oncology, 14, 1182-1190.
https://doi.org/10.1245/s10434-006-9049-1
|
[36]
|
Halliwell, B. (2000) Why and How Should We Measure Oxidative Damage in Nutritional Studies? How Far Could You Come? American Journal of Clinical Nutrition, 72, 1082-1087. https://doi.org/10.1093/ajcn/72.5.1082
|
[37]
|
Tanaka, H., Fujita, N., Sugimoto, R., et al. (2008) Hepatic Oxidative DNA Damage Is Associated with Increased Risk for Hepatocellular Carcinoma in Chronic Hepatitis C. British Journal of Cancer, 98, 580-586.
https://doi.org/10.1038/sj.bjc.6604204
|
[38]
|
Lee, Y.K., Youn, H.G., Wang, H.J. and Yoon, G. (2013) Decreased Mitochondrial OGG1 Expression Is Linked to Mitochondrial Defects and Delayed Hepatoma Cell Growth. Molecules and Cells, 35, 489-497.
https://doi.org/10.1007/s10059-013-2343-4
|
[39]
|
Gorrini, C., Harris, I.S. and Mak, T.W. (2013) Modulation of Oxidative Stress as an Anticancer Strategy. Nature Reviews Drug Discovery, 12, 931-947. https://doi.org/10.1038/nrd4002
|
[40]
|
Dou, C., Xu, Q., Liu, J., et al. (2019) SHMT1 Inhibits the Metastasis of HCC by Repressing NOX1-Mediated ROS Production. Journal of Experimental & Clinical Cancer Research, 38, Article No. 70.
https://doi.org/10.1186/s13046-019-1067-5
|
[41]
|
Li, C., Chen, J., Li, Y., et al. (2021) 6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway. Frontiers in Cell and Developmental Biology, 9, Article 753196.
https://doi.org/10.3389/fcell.2021.753196
|
[42]
|
Li, K.K., Ng, I.O., Fan, S.T., et al. (2002) Activation of Cyclin-Dependent Kinases CDC2 and CDK2 in Hepatocellular Carcinoma. Liver International, 22, 259-268. https://doi.org/10.1046/j.0106-9543.2002.01629.x
|
[43]
|
Suski, J.M., Braun, M., Strmiska, V. and Sicinski, P. (2021) Targeting Cell-Cycle Machinery in Cancer. Cancer Cell, 39, 759-778. https://doi.org/10.1016/j.ccell.2021.03.010
|
[44]
|
Gu, C., Yao, J. and Sun, P. (2017) Dynamin 3 Suppresses Growth and Induces Apoptosis of Hepatocellular Carcinoma Cells by Activating Inducible Nitric Oxide Synthase Production. Oncology Letters, 13, 4776-4784.
https://doi.org/10.3892/ol.2017.6057
|
[45]
|
Dolma, S., Lessnick, S.L., Hahn, W.C. and Stockwell, B.R. (2003) Identification of Genotype-Selective Antitumor Agents Using Synthetic Lethal Chemical Screening in Engineered Human Tumor Cells. Cancer Cell, 3, 285-296.
https://doi.org/10.1016/S1535-6108(03)00050-3
|
[46]
|
Yang, W.S. and Stockwell, B.R. (2008) Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells. Chemistry & Biology, 15, 234-245.
https://doi.org/10.1016/j.chembiol.2008.02.010
|
[47]
|
Tu, H., Tang, L.J., Luo, X.J., et al. (2021) Insights into the Novel Function of System Xc- in Regulated Cell Death. European Review for Medical and Pharmacological Sciences, 25, 1650-1662.
|
[48]
|
Forcina, G.C. and Dixon, S.J. (2019) GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis. Proteomics, 19, e1800311. https://doi.org/10.1002/pmic.201800311
|
[49]
|
Mei, F., Liu, Y. and Zheng, S. (2022) Rhamnazin Inhibits Hepatocellular Carcinoma Cell Aggressiveness in vitro via Glutathione Peroxidase 4-Dependent Ferroptosis. Tohoku Journal of Experimental Medicine, 258, 111-120.
https://doi.org/10.1620/tjem.2022.J061
|
[50]
|
Jin, M., Shi, C., Li, T., et al. (2020) Solasonine Promotes Ferroptosis of Hepatoma Carcinoma Cells via Glutathione Peroxidase 4-Induced Destruction of the Glutathione Redox System. Biomedicine & Pharmacotherapy, 129, Article ID: 110282. https://doi.org/10.1016/j.biopha.2020.110282
|
[51]
|
Yanatori, I. and Kishi, F. (2019) DMT1 and Iron Transport. Free Radical Biology and Medicine, 133, 55-63.
https://doi.org/10.1016/j.freeradbiomed.2018.07.020
|
[52]
|
Gammella, E., Buratti, P., Cairo, G. and Recalcati, S. (2017) The Transferrin Receptor: The Cellular Iron Gate. Metallomics, 9, 1367-1375. https://doi.org/10.1039/C7MT00143F
|
[53]
|
Yu, H., Yang, C., Jian, L., et al. (2019) Sulfasalazine Induced Ferroptosis in Breast Cancer Cells Is Reduced by the Inhibitory Effect of Estrogen Receptor on the Transferrin Receptor. Oncology Reports, 42, 826-838.
https://doi.org/10.3892/or.2019.7189
|
[54]
|
Yang, W.S., Kim, K.J., Gaschler, M.M., et al. (2016) Peroxidation of Polyunsaturated Fatty Acids by Lipoxygenases Drives Ferroptosis. Proceedings of the National Academy of Sciences of the United States of America, 113, E4966-E4975.
https://doi.org/10.1073/pnas.1603244113
|
[55]
|
Lim, K., Han, C., Dai, Y., Shen, M. and Wu, T. (2009) ω-3 Polyunsaturated Fatty Acids Inhibit Hepatocellular Carcinoma Cell Growth through Blocking β-Catenin and Cyclooxygenase-2. Molecular Cancer Therapeutics, 8, 3046-3055.
https://doi.org/10.1158/1535-7163.MCT-09-0551
|
[56]
|
Sun, X.F., Ou, Z.H., Chen, R.C., et al. (2016) Activation of the p62-Keap1-NRF2 Pathway Protects against Ferroptosis in Hepatocellular Carcinoma Cells. Hepatology, 63, 173-184. https://doi.org/10.1002/hep.28251
|
[57]
|
Ghareghomi, S., Habibi-Rezaei, M., Arese, M., Saso, L. and Moosavi-Movahedi, A.A. (2022) Nrf2 Modulation in Breast Cancer. Biomedicines, 10, Article 2668. https://doi.org/10.3390/biomedicines10102668
|
[58]
|
Li, Y., Chen, L., Gao, Y., Zou, X.N. and Wei, F.X. (2022) Oxidative Stress and Intervertebral Disc Degeneration: Pathophysiology, Signaling Pathway, and Therapy. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 1984742.
https://doi.org/10.1155/2022/1984742
|
[59]
|
Feng, X., Jiang, T., Yang, C., et al. (2021) RPRD1A Stabilizes NRF2 and Aggravates HCC Progression through Competing with p62 for TRIM21 Binding. Cell Death &Disease, 13, Article No. 6.
https://doi.org/10.1038/s41419-021-04447-4
|
[60]
|
Aning, O.A. and Cheok, C.F. (2019) Drugging in the Absence of p53. Journal of Molecular Cell Biology, 11, 255-264.
https://doi.org/10.1093/jmcb/mjz012
|
[61]
|
Venkatesh, D., O’brien, N.A., Zandkarimi, F., et al. (2020) MDM2 and MDMX Promote Ferroptosis by PPARα-Mediated Lipid Remodeling. Genes & Development, 34, 526-543. https://doi.org/10.1101/gad.334219.119
|
[62]
|
Zhang, X., Zheng, Q., Yue, X., et al. (2022) ZNF498 Promotes Hepatocellular Carcinogenesis by Suppressing p53-Mediated Apoptosis and Ferroptosis via the Attenuation of p53 Ser46 Phosphorylation. Journal of Experimental & Clinical Cancer Research, 41, Article No. 79. https://doi.org/10.1186/s13046-022-02288-3
|